Congenital hyperinsulinism is a rare but serious genetic condition where the pancreas produces too much insulin, leading to dangerously low blood sugar levels that can affect brain development and overall health in newborns and young children.

Understanding Congenital Hyperinsulinism

Congenital hyperinsulinism, also known as congenital hyperinsulinaemic hypoglycaemia, is a condition where specialized cells in the pancreas called beta cells produce excessive amounts of insulin. Insulin is a hormone that helps move sugar from the bloodstream into the body’s cells for energy. When too much insulin is released, blood sugar levels drop too low, a state called hypoglycaemia. This creates a dangerous situation because the brain relies on a steady supply of sugar to function properly, especially in developing infants and children.^[1]

In healthy individuals, beta cells carefully regulate insulin production based on blood sugar levels. When blood sugar rises after eating, insulin is released. When blood sugar is normal or low, insulin production slows down or stops. However, in people with congenital hyperinsulinism, this finely tuned system doesn’t work properly. The beta cells release insulin continuously, regardless of whether blood sugar is already low. This means that insulin keeps pushing sugar out of the bloodstream even when there isn’t enough to spare.^[2]

The condition is particularly dangerous because excess insulin doesn’t just lower blood sugar—it also blocks the body’s ability to produce ketone bodies, which are alternative fuels the brain can use when glucose is scarce. Without either glucose or ketones available, the brain is left without adequate energy, which can lead to serious and lasting damage if episodes of low blood sugar are frequent or prolonged.^[8]

How Common Is Congenital Hyperinsulinism

Congenital hyperinsulinism is considered a rare condition, though it is the most common cause of persistent low blood sugar in newborns and young children. The condition affects approximately 1 in 50,000 live births in most populations around the world.^[1] However, the frequency varies significantly depending on the population being studied.

In certain communities, particularly those with higher rates of marriages between relatives, congenital hyperinsulinism occurs much more frequently. In some of these populations, the condition can affect as many as 1 in 2,500 newborns, which is twenty times more common than in the general population.^[2] This increased frequency is related to how the genetic mutations that cause the condition are inherited within close-knit communities.

The condition typically becomes apparent early in life. About 60 percent of infants with congenital hyperinsulinism experience their first episode of low blood sugar within the first month after birth. Other affected children may not develop symptoms until early childhood. The timing can vary widely, even among members of the same family who carry the same genetic mutation.^[2]

Despite being relatively rare, congenital hyperinsulinism is a significant concern in neonatal intensive care units. Because most children’s hospitals encounter only one or two cases per year, many healthcare providers have limited experience with the condition. This makes it especially important for affected families to seek care at specialized treatment centers with expertise in managing this complex disorder.^[6]

What Causes Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations—changes in the genetic code that affect how beta cells in the pancreas function. These mutations disrupt the normal processes that regulate insulin secretion, causing the beta cells to release too much insulin regardless of blood sugar levels.^[2]

Researchers have identified mutations in at least nine genes that can cause congenital hyperinsulinism. Each of these genes normally plays an important role in controlling when and how much insulin is released. When mutations occur in these genes, the carefully balanced system breaks down, leading to uncontrolled insulin secretion.^[2]

The most commonly affected gene is called ABCC8, which accounts for approximately 40 percent of cases where the genetic cause is identified. Another gene, KCNJ11, is also frequently involved. Both of these genes provide instructions for making parts of potassium channels in beta cells, which are critical for regulating insulin release. When these channels don’t work properly, insulin pours out continuously.^[2]

Other genes associated with congenital hyperinsulinism include GLUD1, GCK, HADH, HNF4A, HNF1A, SLC16A1, UCP2, HK1, PGM1, and PMM2. Mutations in each of these genes are less common but can still cause significant problems with insulin regulation.^[9] Despite advances in genetic testing, approximately half of all people with congenital hyperinsulinism have no identified genetic mutation, suggesting that additional genes remain to be discovered.^[2]

The genetic mutations can occur spontaneously, meaning they happen by chance and are not inherited from parents. Alternatively, they can be passed down from one or both parents. The inheritance pattern depends on which gene is affected and the specific type of mutation involved.^[12]

Risk Factors for Developing Congenital Hyperinsulinism

Because congenital hyperinsulinism is a genetic condition present at birth, traditional risk factors like lifestyle or environmental exposures don’t apply in the same way they do for many other diseases. However, certain circumstances increase the likelihood that a baby will be born with this condition.

Family history plays a significant role. If one or both parents carry genetic mutations associated with congenital hyperinsulinism, their children may be at increased risk. The specific risk depends on the inheritance pattern of the mutation involved. In some cases, both parents must pass on a mutated gene for a child to develop the condition. In other cases, inheriting just one mutated gene from one parent is sufficient.^[2]

Populations with higher rates of consanguinity—marriages between close relatives—have higher rates of congenital hyperinsulinism. This is because related individuals are more likely to carry the same genetic mutations, increasing the chance that both parents will pass along the same problematic gene to their child.^[2]

There is also a transient form of hyperinsulinism that affects some newborns temporarily. This form is associated with specific risk factors including prematurity, maternal diabetes during pregnancy (especially if poorly controlled), significant heart disease, and severe infections in the pregnant mother. In these cases, the hyperinsulinism typically resolves within weeks to months as the baby matures.^[12]

Babies born to mothers with gestational diabetes or poorly controlled diabetes may have temporary hyperinsulinism because they were exposed to high blood sugar levels in the womb. The baby’s pancreas responds by producing extra insulin, and this overproduction can continue briefly after birth even though the baby is no longer receiving high levels of sugar from the mother.

Recognizing the Symptoms

The symptoms of congenital hyperinsulinism stem directly from low blood sugar and its effects on the body, particularly the brain. The severity and type of symptoms can vary considerably among affected individuals, ranging from subtle signs that might be easily missed to dramatic, life-threatening episodes.^[2]

In newborns and infants, the symptoms are often nonspecific, making diagnosis challenging. Affected babies may show poor feeding, meaning they don’t eat well or seem uninterested in nursing or taking a bottle. They may appear unusually sleepy or lethargic, lacking the alertness typical of healthy newborns. Irritability and fussiness that seems excessive or unusual can also be warning signs. Some babies experience episodes where they temporarily stop breathing, called apnoea, or develop abnormally low body temperature, known as hypothermia.^[1]

More serious symptoms include seizures, which occur when the brain doesn’t receive enough glucose to function properly. These seizures can be subtle or obvious, and they represent a medical emergency. In severe cases, affected infants may become unresponsive or fall into a coma. If low blood sugar is not promptly corrected, permanent brain damage can occur, potentially leading to intellectual disability, developmental delays, vision loss, and long-term neurological problems.^[2]

During physical examination, healthcare providers may notice other signs. Some newborns with congenital hyperinsulinism develop cardiomyopathy, a condition where the heart muscle doesn’t work properly. The liver may become enlarged, a condition called hepatomegaly, which can be felt during examination of the abdomen.^[1]

In older children, symptoms may include sudden onset of hunger, shakiness or trembling, sweating, pallor (loss of normal skin color), rapid breathing, confusion, and changes in behavior. Some children experience a bluish discoloration around the mouth, called cyanosis, during episodes of low blood sugar.^[12]

Unlike typical episodes of hypoglycaemia in healthy individuals, which usually occur after periods of fasting or heavy exercise, episodes in people with congenital hyperinsulinism can occur even after eating. This is because the excessive insulin continues to drive blood sugar down regardless of recent food intake.^[2]

Preventing Complications

Because congenital hyperinsulinism is a genetic condition, there is no known way to prevent the condition itself from developing. However, preventing the serious complications that result from repeated episodes of low blood sugar is absolutely critical. The focus of prevention efforts centers on early detection, prompt diagnosis, and maintaining blood sugar levels within a safe range.

For families with a known history of congenital hyperinsulinism, genetic counseling before pregnancy can help parents understand their risk of having an affected child and discuss available options. During pregnancy, awareness of maternal diabetes and its proper management can help reduce the risk of transient hyperinsulinism in the newborn.^[12]

Once a baby is diagnosed with congenital hyperinsulinism, preventing hypoglycaemic episodes becomes the primary goal. This requires frequent monitoring of blood sugar levels, especially during times when the baby or child is sleeping or hasn’t eaten recently. Many families learn to check blood sugar at home using small devices that require only a drop of blood from a finger prick.

Continuous glucose monitoring systems, which use a small sensor placed under the skin to track blood sugar levels throughout the day and night, have become valuable tools for families managing congenital hyperinsulinism. These systems can alert caregivers when blood sugar is dropping before symptoms appear, allowing intervention before a crisis develops.^[13]

Maintaining appropriate feeding schedules is essential. Infants with congenital hyperinsulinism often need to eat more frequently than healthy babies to keep their blood sugar from dropping too low. Some may require special formulas or feeding regimens designed to provide a steady supply of nutrients. In severe cases, continuous feeding through a gastric tube may be necessary, particularly during the night when long periods without eating pose the greatest risk.

Education for family members, caregivers, teachers, and anyone who spends significant time with an affected child is crucial. These individuals need to recognize early warning signs of low blood sugar and know how to respond appropriately. Having emergency supplies readily available—including fast-acting sources of sugar and emergency glucagon injections—can make the difference in preventing serious outcomes.

Regular follow-up with specialized healthcare providers who understand congenital hyperinsulinism ensures that treatment plans are adjusted as the child grows and their needs change. Monitoring for potential complications and side effects of treatments is also an important aspect of long-term prevention strategies.

How the Body’s Normal Processes Are Disrupted

Understanding what goes wrong in congenital hyperinsulinism requires looking at how beta cells normally regulate insulin secretion. In healthy individuals, beta cells act like sophisticated sensors that constantly monitor blood glucose levels and adjust insulin production accordingly. When blood glucose rises after a meal, beta cells increase insulin secretion. This insulin helps move glucose from the bloodstream into cells throughout the body, where it can be used for energy or stored for later use.^[7]

The process of insulin secretion in normal beta cells involves several steps. Glucose enters the beta cell and is broken down, generating energy in the form of molecules called ATP. The increase in ATP causes specific potassium channels in the cell membrane to close. These channels, known as KATP channels, play a critical role in regulating the cell’s electrical activity. When they close, the cell membrane becomes electrically charged, triggering the release of insulin that has been stored in tiny packages within the cell.^[9]

In congenital hyperinsulinism, this carefully orchestrated process breaks down. The specific disruption depends on which gene is mutated. In cases involving mutations in the ABCC8 or KCNJ11 genes, the KATP channels don’t function properly. They may remain closed even when blood glucose is low, causing continuous insulin release. This is like having a faucet that won’t turn off—insulin keeps flowing regardless of whether it’s needed.^[2]

Other genetic mutations affect different parts of the insulin secretion pathway. Some mutations cause the beta cells to be overly sensitive to glucose, so even small amounts trigger excessive insulin release. Others disrupt the cell’s ability to process amino acids from protein, leading to inappropriate insulin secretion after protein-containing meals. Still others affect the mitochondria, the energy-producing structures within cells, causing dysregulation of the entire system.^[9]

The excessive insulin secretion has multiple effects on the body’s metabolism. First and most obviously, it causes blood glucose to drop as insulin drives glucose into cells. But insulin also affects fat metabolism. It stimulates the creation of fat stores and prevents the breakdown of fat to produce alternative fuels. Normally, when blood glucose drops, the body responds by breaking down fat into free fatty acids and converting them into ketone bodies that the brain can use for energy. However, excessive insulin blocks this protective mechanism.^[9]

Insulin also inhibits the liver’s ability to produce new glucose through a process called gluconeogenesis and prevents the breakdown of stored glycogen back into glucose. These processes normally help maintain blood sugar during fasting. When insulin is constantly elevated, these backup systems are shut down, leaving the person vulnerable to severe hypoglycaemia without any alternative fuel sources available.^[9]

The result is a metabolic crisis where blood glucose falls rapidly and the brain is deprived of both its primary fuel (glucose) and its backup fuels (ketones and free fatty acids). This explains why hypoglycaemia in congenital hyperinsulinism is particularly dangerous and why it requires more aggressive treatment than other forms of low blood sugar. The suppression of ketone body formation means there is no safety net—the brain has no alternative energy source to rely on when glucose runs out.^[8]

There are two main patterns of beta cell dysfunction in congenital hyperinsulinism, described as focal and diffuse forms. In the diffuse form, beta cells throughout the entire pancreas are affected, all secreting too much insulin. In the focal form, only a localized area of abnormal beta cells exists, while the rest of the pancreas functions normally. Approximately 40 percent of cases are focal, 50 percent are diffuse, and 10 percent are considered atypical, showing characteristics that don’t fit neatly into either category.^[3]

Under the microscope, affected areas of the pancreas show characteristic changes. There are clusters of cells that look like small islands, along with abnormal connections between insulin-producing cells and the pancreatic ducts. The cells themselves appear enlarged with oversized nuclei and show signs of being metabolically very active, with well-developed structures for protein production—consistent with cells that are working overtime to produce and secrete insulin.^[3]